MiGo Tracker Remote Monitoring of Home Exercise After Stroke
MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Experienced one or more strokes less than one month (30 days) prior * Upper Extremity Fugl-Meyer Score \> 5 and \<= 55 out of 66 * Absence of moderate to severe pain (\<= 4 on the 10 point visual-analog pain scale) Exclusion Criteria: * age \<18 years old * Unable to follow 2-step commands * Other neurological diagnosis (e.g. Parkinson's Disease) * Other severe concurrent medical conditions that may prevent the participants from completing the 3-month study
About the study
This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.
What is being tested
- MiGo Tracker (device)
- Conventional home exercise program (other)
Sponsor: Flint Rehabilitation Devices, LLC · Participants: 50 · Started: Jun 11, 2025
Contact the study team
- Ian M Russell, PhD · Phone: 3392232676
- Daniel Zondervan, PhD · Phone: 949-313-7322
Official record on ClinicalTrials.gov — NCT06752707
Locations in the U.S.
| California | Rancho Research Institute, Inc, Downey |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.